ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

NCI Cancer Center Support Grants Listed, 1989 vs. 1995

March 22, 1996

Stronger Federal Role Needed To Improve Palliative Care.

June 22, 2001

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001